BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 14627847)

  • 1. Comparative impact of standard approach, FDG PET and FDG dual-head coincidence gamma camera imaging in preoperative staging of patients with non-small-cell lung cancer.
    Delahaye N; Crestani B; Rakotonirina H; Lebtahi R; Sarda L; Girard P; Charpentier E; Fery-Lemonnier E; Syrota A; Aubier M; Le Guludec D
    Nucl Med Commun; 2003 Dec; 24(12):1215-24. PubMed ID: 14627847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer.
    Eschmann SM; Bitzer M; Paulsen F; Friedel G; Besenfelder H; Horger M; Reimold M; Dittmann H; Pfannenberg AC; Bares R
    Nucl Med Commun; 2004 Sep; 25(9):909-15. PubMed ID: 15319596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of lung cancer with fluorine-18 fluorodeoxyglucose: comparison of a dual-head gamma camera in coincidence mode with a full-ring positron emission tomography system.
    Weber WA; Neverve J; Sklarek J; Ziegler SI; Bartenstein P; King B; Treumann T; Enterrottacher A; Krapf M; Häussinger KE; Lichte H; Präuer HW; Thetter O; Schwaiger M
    Eur J Nucl Med; 1999 Apr; 26(4):388-95. PubMed ID: 10199945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of FDG PET and positron coincidence detection imaging using a dual-head gamma camera with 5/8-inch NaI(Tl) crystals in patients with suspected body malignancies.
    Boren EL; Delbeke D; Patton JA; Sandler MP
    Eur J Nucl Med; 1999 Apr; 26(4):379-87. PubMed ID: 10199944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG PET and dual-head gamma camera positron coincidence detection imaging of suspected malignancies and brain disorders.
    Delbeke D; Patton JA; Martin WH; Sandler MP
    J Nucl Med; 1999 Jan; 40(1):110-7. PubMed ID: 9935066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma.
    Poncelet AJ; Lonneux M; Coche E; Weynand B; Noirhomme P;
    Eur J Cardiothorac Surg; 2001 Sep; 20(3):468-74; discussion 474-5. PubMed ID: 11509265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging and managing lung tumors using F-18 FDG coincidence detection.
    Roman MR; Rossleigh MA; Angelides S; Walker BM; Dixon J
    Clin Nucl Med; 2001 May; 26(5):383-8. PubMed ID: 11317014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
    Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K
    Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of recurrent and advanced lung cancer with 18F-FDG PET in a coincidence technique (hybrid PET).
    Schmid RA; Hautmann H; Poellinger B; Kellner W; Moisseev A; Brinkbaeumer K; Weiss M; Hahn K; Dresel S
    Nucl Med Commun; 2003 Jan; 24(1):37-45. PubMed ID: 12501018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimisation of the OS-EM algorithm and comparison with FBP for image reconstruction on a dual-head camera: a phantom and a clinical 18F-FDG study.
    Gutman F; Gardin I; Delahaye N; Rakotonirina H; Hitzel A; Manrique A; Le Guludec D; Véra P
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1510-9. PubMed ID: 14579091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer.
    Stokkel MP; Bakker PF; Heine R; Schlösser NJ; Lammers JW; Van Rijk PP
    Nucl Med Commun; 1999 Nov; 20(11):1001-7. PubMed ID: 10572909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
    Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
    J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J; Milleron B; Vaylet F; Grahek D; Lebeau B; Mangiapan G; Bonardel G; de Labriolle-Vaylet C; Meignan M; Carette MF; Talbot JN; Housset B
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
    Berlangieri SU; Scott AM; Knight SR; Fitt GJ; Hennessy OF; Tochon-Danguy HJ; Clarke CP; McKay WJ
    Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S25-30. PubMed ID: 10536941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of positron emission tomography for lung cancer staging.
    Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
    Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of iterative reconstruction, attenuation correction, and image fusion in the interpretation of FDG PET images with an integrated dual-head coincidence camera and X-ray-based attenuation maps.
    Delbeke D; Martin WH; Patton JA; Sandler MP
    Radiology; 2001 Jan; 218(1):163-71. PubMed ID: 11152796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment.
    Mac Manus MP; Hicks RJ; Ball DL; Kalff V; Matthews JP; Salminen E; Khaw P; Wirth A; Rischin D; McKenzie A
    Cancer; 2001 Aug; 92(4):886-95. PubMed ID: 11550162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.